Life Technologies Corporation
LIFE today announced that iGenomics, a privately held diagnostic
service company based in Guangzhou, China, purchased 17 Ion Proton™ sequencers
and plans to add 15 more instruments by the end of the year. iGenomics, which
also signed a licensing and supply agreement with Life Technologies, will
initially use the sequencers for research in aneuploidy screening, but plans
to expand into other research applications.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in